Calise Chris 4
4 · Coeptis Therapeutics Holdings, Inc. · Filed Aug 31, 2023
Insider Transaction Report
Form 4
Calise Chris
Director
Transactions
- Purchase
Common Stock
2023-08-23$0.94/sh+9,000$8,460→ 1,462,315 total - Purchase
Common Stock
2023-08-23$0.94/sh+2,582$2,419→ 1,464,897 total
Footnotes (1)
- [F1]Includes (i) 942,117 shares of common stock that are issuable under currently exercisable options and (ii) 7,500 shares of common stock that are issuable upon exercise of options that will become exercisable. Does not include 22,500 shares of common stock that are issuable upon exercise of options that are not currently exercisable and will not become exercisable in the next 60 days.